True North Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $396K | Buy |
5,732
+2,232
| +64% | +$154K | 0.08% | 154 |
|
|
2025
Q1 | $243K | Sell |
3,500
-1,680
| -32% | -$117K | 0.04% | 222 |
|
|
2024
Q4 | $446K | Buy |
5,180
+100
| +2% | +$8.6K | 0.11% | 107 |
|
|
2024
Q3 | $605K | Buy |
5,080
+225
| +5% | +$26.8K | 0.16% | 91 |
|
|
2024
Q2 | $693K | Sell |
4,855
-265
| -5% | -$37.8K | 0.19% | 88 |
|
|
2024
Q1 | $657K | Hold |
5,120
| – | – | 0.18% | 92 |
|
|
2023
Q4 | $530K | Buy |
5,120
+1,770
| +53% | +$183K | 0.14% | 100 |
|
|
2023
Q3 | $305K | Sell |
3,350
-1,770
| -35% | -$161K | 0.09% | 146 |
|
|
2023
Q2 | $414K | Buy |
+5,120
| New | +$414K | 0.12% | 130 |
|